The Friday Report is our regular fortnightly update with a summary of the key papers and analyses that we’ve looked at recently. Issue 60 includes:
- Vaccine effectiveness against Delta and Omicron
- Durability of Omicron-neutralising effect – mRNA boosters in the elderly
- Novavax approved in the UK for ages 12 plus
- More transmissible BA.2 variant likely to quickly achieve global dominance
- Safety and viral kinetics in a SARS-CoV-2 ‘human challenge’ trial
- Rapid Antigen Testing – is 5 days of isolation for COVID-19 sufficient?
- Hospitalisations in England – how it’s going against model projections
- Obesity and ethnicity interaction in COVID-19 hospitalisation / mortality
- ONS infectivity and antibody updates
- Deaths by vaccination status
- Increasing divergence between UKHSA and ONS definitions of COVID-19 deaths
And finally, for our ‘Diamond Jubilee’ 60th issue, we report on a Jubilee spelling variant …